Source: Annual Congress 2009 - Pulmonary circulation
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Gaber, N. Sommer, N. Huang, A. Ghofrani, R. Schermuly, W. Seeger, F. Grimminger, J. Cooke, N. Weissmann (Giessen, Germany; Stanford, United States Of America). Hypoxia induced pulmonary hypertension – the role of dimethylarginine dimethylaminohydrolase 1 (DDAH-1) in acute and sustained hypoxic vasoconstriction. Eur Respir J 2009; 34: Suppl. 53, 1880

Member's Comments

No comment yet.

Related content which might interest you: Attenuated expression and activity of dimethylarginine dimethylaminohydrolase may play a key role in monocrotaline-induced pulmonary hypertension by accumulation of endogenous NOS inhibitors in rats Source: Annual Congress 2006 - Signalisation in the pulmonary vasculature: new pathways and wrong signals Year: 2006 Increased alveolar epithelial expression of dimethylarginine dimethylaminohydrolase 2 in idiopathic pulmonary fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 823s Year: 2006 Asymmetric dimethylarginine (ADMA) to monitor treatments of pulmonary hypertension Source: International Congress 2019 – Endpoints and risk assessment of pulmonary arterial hypertension Year: 2019 Lipopolysaccharide attenuates endothelial barrier function through a pp60Src mediated inhibition of dimethylaminohydrolase (DDAH) Source: Annual Congress 2011 - Barrier functions in sepsis and acute lung injury Year: 2011 High-altitude pulmonary hypertension Source: Eur Respir Rev 2009; 18: 13-17 Year: 2009 Expression of endothelial nitric oxide synthase (eNOS) and endothelin-1 (ET-1) in pulmonary arteries of patients with severe COPD Source: Annual Congress 2003 - Pathophysiology of the pulmonary circulation Year: 2003 Endogenous endothelins and nitric oxide in hypoxic pulmonary vasoconstriction Source: Eur Respir J 2003; 21: 19-24 Year: 2003 Correlation of inhaled nitric-oxide induced reduction of pulmonary artery pressure and vascular changes Source: Eur Respir J 2002; 20: 52-58 Year: 2002 Shroom expression is attenuated in hypoxia-induced pulmonary hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 147s Year: 2006 Tetrahydrobiopterin and the regulation of hypoxic pulmonary vasoconstriction Source: Eur Respir J 2010; 36: 323 Year: 2010 Biomarkers in pulmonary hypertension Source: Eur Respir J 2008; 32: 503-512 Year: 2008 Cirrhosis ameliorates monocrotaline-induced pulmonary hypertension in rats Source: Eur Respir J 2009; 34: 731 Year: 2009 Effect of the Asp298 variant of endothelial nitric oxide synthase on acute pulmonary vasodilator testing response in idiopathic pulmonary arterial hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 547s Year: 2006 The effect of bosentan in occlusive pulmonary hypertension in rats – Role of oxidative and nitrative stress attenuation Source: Annual Congress 2010 - Pulmonary vascular diseases Year: 2010 Effects of hypobaric hypoxia on circulating microRNA expression and hypoxic pulmonary vasoconstriction Source: International Congress 2016 – Pulmonary hypertension: novel insights Year: 2016 TRAM-34 ameliorates hypoxia-induced pulmonary arterial hypertension in rats Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments Year: 2013 Role of the nitric oxide-asymmetric dimethylarginine-dimethylarginine dimethylaminohydrolase (NO-ADMA-DDAH) axis in TGF-β mediated epithelial-mesenchymal transition Source: International Congress 2015 – IPF: from bench to bedside Year: 2015 Effects of the NO donor molsidomine on prostacyclin synthase gene expression in rats with chronic hypoxic pulmonary hypertension Source: Eur Respir J 2001; 18: Suppl. 33, 414s Year: 2001 Role of hypoxia inducible factor 1alpha (HIF-1alpha) in delayed myocardial preconditioning induced by intermittent hypoxia (IH) in the rat Source: Annual Congress 2006 - Taormina 4th ERS Lung Science Conference "hypoxia in lung biology and disease" Year: 2006 Atrial natriuretic peptide plasma concentration (ANP) and pulmonary hemodynamics (HEMO) after acute nitric oxide inhalation (NO) in patients with connective tissue disease and pulmonary artery hypertension (CTDPH) Source: Eur Respir J 2005; 26: Suppl. 49, 561s Year: 2005